×
About 26,448 results

ALLMedicine™ Abdominal Pain Center

Research & Reviews  8,885 results

Pharmacological intervention for paediatric irritable bowel syndrome.
https://doi.org/10.1080/14656566.2021.1976753
Expert Opinion on Pharmacotherapy; Pesce M, Puoti MG et. al.

Sep 16th, 2021 - Irritable bowel syndrome is a common functional gastrointestinal disorder in children, characterized by recurrent abdominal pain associated with altered bowel habits in terms of both frequency and consistency. According to change in stool consiste...

A prospective longitudinal study of chronic abdominal pain and symptoms after sleeve ga...
https://doi.org/10.1016/j.soard.2021.07.014
Surgery for Obesity and Related Diseases : Official Journ... Chahal-Kummen M, Nordahl M et. al.

Sep 15th, 2021 - Sleeve gastrectomy (SG) is widely applied. Few studies have evaluated patient-reported abdominal symptoms after SG. To evaluate the prevalence of chronic abdominal pain (CAP) and symptom characteristics after SG. Oslo University Hospital and Voss ...

Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a ra...
https://doi.org/10.1136/bmjopen-2020-045655
BMJ Open; Zhao J, Chen M et. al.

Sep 15th, 2021 - Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder that presents with abdominal pain/discomfort and altered bowel patterns. IBS has multiple potential causes for which conventional medicines have had limited su...

Improvement in constipation and diarrhea is associated with improved abdominal pain in ...
https://doi.org/10.1111/nmo.14253
Neurogastroenterology and Motility : the Official Journal... Rangan V, Singh P et. al.

Sep 15th, 2021 - Abdominal pain is a bothersome and lifestyle limiting symptom in patients with functional bowel disorders. It is associated with decreased quality of life in affected individuals, as well as significant annual healthcare expenditure. Knowledge of ...

see more →

Guidelines  15 results

Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular...
https://doi.org/10.1016/j.jvs.2020.10.029
Journal of Vascular Surgery; Huber TS, Björck M et. al.

Nov 11th, 2020 - Chronic mesenteric ischemia (CMI) results from the inability to achieve adequate postprandial intestinal blood flow, usually from atherosclerotic occlusive disease at the origins of the mesenteric vessels. Patients typically present with postprand...

AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.
https://doi.org/10.1053/j.gastro.2020.06.090
Gastroenterology Quigley EM, Murray JA et. al.

Jul 18th, 2020 - Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implica...

ACR Appropriateness Criteria® Suspected Small-Bowel Obstruction.
https://doi.org/10.1016/j.jacr.2020.01.025
Journal of the American College of Radiology : JACR; , Chang KJ et. al.

May 7th, 2020 - Small-bowel obstruction is a common cause of abdominal pain and accounts for a significant proportion of hospital admissions. Radiologic imaging plays the key role in the diagnosis and management of small-bowel obstruction as neither patient prese...

ACR Appropriateness Criteria® Right Upper Quadrant Pain.
https://doi.org/10.1016/j.jacr.2019.02.013
Journal of the American College of Radiology : JACR; , Peterson CM et. al.

May 6th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

ACR Appropriateness Criteria® Acute Nonlocalized Abdominal Pain.
https://doi.org/10.1016/j.jacr.2018.09.010
Journal of the American College of Radiology : JACR; , Scheirey CD et. al.

Nov 6th, 2018 - The range of pathology in adults that can produce abdominal pain is broad and necessitates an imaging approach to evaluate many different organ systems. Although localizing pain prompts directed imaging/management, clinical presentations may vary ...

see more →

Drugs  350 results see all →

Clinicaltrials.gov  16 results

The Utility of Immature Granulocyte Count on the Prediction of Acute Appendicitis in the Suspected Acute Appendicitis
https://clinicaltrials.gov/ct2/show/NCT05033249

Sep 2nd, 2021 - Acute appendicitis is the most common cause of abdominal pain requiring surgery in the emergency department. The highest incidence of acute appendicitis is in the 2nd and 3rd decades of life, but it can be seen at any age. There is a 7% chance tha...

Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression
https://clinicaltrials.gov/ct2/show/NCT05030064

Sep 1st, 2021 - A total of 54 patients with definite diagnosis of ulcerative colitis (light-to-moderate active period) with depressive state were included. According to the random table, patients were randomly divided into the FMT capsule group and the placebo gr...

Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
https://clinicaltrials.gov/ct2/show/NCT01335945

Jul 16th, 2021 - CUC10-PAN09 is a Supportive Care, Phase 1 multicenter, prospective, single arm study with subjects serving as their own control. This study is to enroll patients who will undergo cryoablation of the Celiac Plexus. Subjects will be followed for 3 m...

High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department
https://clinicaltrials.gov/ct2/show/NCT04398316

Feb 24th, 2021 - Abdominal pain is a common chief complaint for patients presenting to the emergency department (ED) in the United States. Intravenous opioids are commonly used to treat acute abdominal pain in the ED. These medications are highly efficacious and, ...

Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
https://clinicaltrials.gov/ct2/show/NCT04332627

Dec 24th, 2020 - Quality of Recovery questionnaire includes five details (Emotional status, Physical comfort, Physiological support, Physical independece, Pain), and is a proven method of reliability, consistency and validity for evaluating recovery from surgery a...

see more →

News  1,302 results

The Peculiar Timing of Death
https://www.medscape.com/viewarticle/954024

Jul 14th, 2021 - I have spent my entire career in geriatric medicine. But a lesson I learned early on as an intern has served as a guiding reminder throughout my career. Mark E. Williams, MD It was the third month of my internal medicine internship on the oncology...

Upadacitinib May Help Relieve Troubling Symptoms in Ulcerative Colitis
https://www.medscape.com/viewarticle/954254

Jul 7th, 2021 - NEW YORK (Reuters Health) - Upadacitinib, an oral selective Janus kinase (JAK)-1 inhibitor, may reduce symptoms and improves quality of life in patients with ulcerative colitis (UC), according to a post hoc analysis of data from a clinical trial. ...

Higher Dose of Ripretinib Improves Outcomes in Heavily Pretreated Advanced GIST
https://www.onclive.com/view/higher-dose-of-ripretinib-improves-outcomes-in-heavily-pretreated-advanced-gist

Jun 18th, 2021 - Intra-patient dose escalation (IPDE) of ripretinib (Qinlock) to 150 mg twice daily following disease progression extended progression-free survival (PFS) for patients with advanced gastrointestinal stromal tumor (GIST) after receiving fourth-line ...

Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon 
https://www.medscape.com/viewarticle/952426

Jun 3rd, 2021 - A novel, ultra-long-acting oral formulation of the antipsychotic risperidone (Risperdal) only needs to be taken once weekly and appears to be safe and effective, results of a new phase 2 study suggest. The new formulation, LYN-005 (Lyndra Therapeu...

FDA Approves Ibrexafungerp for Vaginal Yeast Infection
https://www.medscape.com/viewarticle/952312

Jun 2nd, 2021 - The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafemme) as a 1-day oral therapy for vaginal yeast infections, something 3 out of every 4 women encounter at least once in their life. Ibrexafungerp is the first drug...

see more →

Patient Education  11 results see all →